SC0062

· Biocity Biopharmaceutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SC0062, covering 2025-01-07 to 2025-01-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease [Phase 2]